Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Ajanta Pharma Told to Revise BE Study Protocol for Cilnidipine, Metoprolol FDC

Ajanta Pharma Gets Relief in Erectile Dysfunction Drug Export Case, Penalty Set Aside

Farhat Nasim31 July 2025 11:34 PM IST

Mumbai: In relief to Ajanta Pharma Ltd, the Customs, Excise & Service Tax Appellate Tribunal (CESTAT), Mumbai has set aside a Rs 2 lakh penalty...

NPPA Panel Defers Biological E's Pneumonia Vaccine Price Exemption, Seeks Clarification

Farhat Nasim31 July 2025 11:00 PM IST

New Delhi: The National Pharmaceutical Pricing Authority (NPPA)'s Multidisciplinary Committee of Experts has asked Biological E Limited to submit...

Aurobindo Pharmas subsidiary CuraTeQ Biologics Secures MHRA Approval for Trastuzumab Biosimilar Dazublys in HER2-Positive Cancer

Aurobindo Pharma Acquires Lannett for Rs 2,185 Cr to Boost U.S. Presence, ADHD Line

Farhat Nasim31 July 2025 2:48 PM IST

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo Pharma USA Inc, has entered...

Novo Nordisk Gets CDSCO Panel Nod for Rybelsus Label Update, Aligned with EMA

Novo Nordisk Appoints Mike Doustdar as New CEO Amid Executive Reshuffle

Farhat Nasim31 July 2025 2:30 PM IST

Delhi: Global healthcare major Novo Nordisk has announced the appointment of Maziar Mike Doustdar as its new President and Chief Executive Officer,...

B.Pharm Students Certificates Withheld: Telangana HRC Pulls Up Nalgonda Pharmacy College

Pharmacy Colleges in Trouble: Maharashtra Cracks Down on Institutions Failing PCI Standards

Farhat Nasim30 July 2025 6:06 PM IST

Mumbai: The Maharashtra government has issued a strong ultimatum to all B.Pharm and D.Pharm colleges in the state: comply with Pharmacy Council of...

Torrent Pharma Gears Up to Launch Oral, Injectable Semaglutide in 2026 Post Patent Expiry: Report

Farhat Nasim29 July 2025 10:09 PM IST

New Delhi: Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes and weight loss...

Trademark Clash: UNWANTED-72 Packaging Blocked, MISTAKE-72 Name Cleared by Delhi HC

Roche Slammed for Seeking Zydus' Confidential Process for Cancer Drug Sigrima Without Meeting Patent Threshold

Farhat Nasim28 July 2025 6:29 PM IST

New Delhi: In a major relief to Zydus Lifesciences, the Delhi High Court dismissed F. Hoffmann-La Roche's plea seeking disclosure of Zydus'...

Pharma Firm Ignored Safety Gaps Before Deadly Blast, Paid Rs 32 Cr To Victims, Parliament Informed

Farhat Nasim27 July 2025 1:00 PM IST

New Delhi: In the aftermath of the fatal explosion at Escientia Advanced Sciences Pvt. Ltd. in Anakapalli, Andhra Pradesh, the Parliament was recently...

Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact

Sun Pharma Agrees To Rs 1,654 Cr Settlement In U.S. Pricing Row

Farhat Nasim25 July 2025 5:29 PM IST

New Delhi: Sun Pharmaceutical Industries Ltd. has announced that its U.S. subsidiaries, Sun Pharmaceutical Industries Inc. and Taro Pharmaceuticals...

Revise Phase III Trial Protocol for Roflumilast Cream: CDSCO Panel Tells Sun Pharma

No Special Price for Novel Pack: NPPA Panel Turns Down Sun Pharma's Amoxicillin-Clavulanic Formulation

Farhat Nasim25 July 2025 5:24 PM IST

New Delhi: In a regulatory pushback against what it deemed an ineligible pricing request, the Multi-Disciplinary Committee (MDC) of the National...

NPPA Panel Rejects Dr Reddy's Omez ODT Plea For Seperate Price, Finds No Therapeutic Edge

Farhat Nasim24 July 2025 6:54 PM IST

New Delhi: In a decisive move against what it viewed as an unjustified price escalation, the Multi-Disciplinary Committee (MDC) under India's drug...

Zydus Gets CDSCO Panel Nod to Market Sodium Chloride Nebuliser Solution

Delhi HC Bars Zydus From Launching Cancer Drug Nivolumab Biosimilar Till 2026

Farhat Nasim23 July 2025 4:45 PM IST

New Delhi: In a major setback to Zydus Lifesciences, the Delhi High Court has restrained the company from launching its proposed biosimilar of the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok